National Academy of Medicine January 18, 2022
At the start of a new year, experts are encouraged by continuing progress in cancer care, such as immunotherapies and precision treatments.
However, if we’re not careful, disparities in who gets access to high-quality cancer care and treatments could persist and be exacerbated, said panelists at a recent National Academies workshop on promoting health equity in cancer care.
“We’re not always putting the social determinants of health first … We’re dealing with people — not just cancer.”
“In cancer care, we’re always thinking about the newest medication, the newest technology, but we’re not always putting the social determinants of health first,” said Lisa C. Richardson, division director for cancer control at the Centers for Disease Control and Prevention. “We’re dealing...